Dabigatran Etexilate Versus Warfarin in the Treatment of Venous Thromboembolism

被引：0
|
作者：
Schulman, Sam [1 ]
Eriksson, Henry [2 ]
Goldhaber, Samuel Z. [3 ]
Kakkar, Ajay K. [4 ]
Kearon, Clive [5 ]
Mismetti, Patrick [6 ]
Schellong, Sebastian M. [7 ]
Baanstra, David [8 ]
Schnee, Janet [9 ]
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] Sahlgrens Univ Hosp, Gothenburg, Sweden
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Barts & London Queen Marys Sch Med & Dent, Thrombosis Res Inst, London, England
[5] McMaster Univ Clin, Henderson Hosp, Hamilton, ON, Canada
[6] Bellevue Hosp, St Etienne, France
[7] Municipal Hosp Friedrichstadt, Med Div 2, Dresden, Germany
[8] Boehringer Ingelheim GmbH & Co KG, Clin Res, Alkmaar, Netherlands
[9] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Dabigatran for the treatment of venous thromboembolism
    Schellong, Sebastian M.
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 413 - 425
  • [22] Bleeding events with dabigatran or warfarin in patients with venous thromboembolism
    Majeed, Ammar
    Goldhaber, Samuel Z.
    Kakkar, Ajay
    Kearon, Clive
    Eriksson, Henry
    Kreuzer, Joerg
    Feuring, Martin
    Hantel, Stephan
    Friedman, Jeffrey
    Schellong, Sebastian
    Schulman, Sam
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 291 - 298
  • [23] Dabigatran versus Warfarin for the Treatment of Pediatric Thromboembolism: A Pilot Randomized Trial
    Eghbali, Aziz
    Afzal, Roghayyeh Rahimi
    Sheykhbeygloo, Roya
    Eghbali, Aygin
    Taherkhanchi, Bahar
    Bagheri, Bahador
    PHARMACEUTICAL SCIENCES, 2020, 26 (03) : 338 - 342
  • [24] Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
    Schulman, Sam
    Kearon, Clive
    Kakkar, Ajay K.
    Schellong, Sebastian
    Eriksson, Henry
    Baanstra, David
    Kvamme, Anne Mathilde
    Friedman, Jeffrey
    Mismetti, Patrick
    Goldhaber, Samuel Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08): : 709 - 718
  • [25] Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
    Bueller, Harry R.
    Decousus, Herve
    Grosso, Michael A.
    Mercuri, Michele
    Middeldorp, Saskia
    Prins, Martin H.
    Raskob, Gary E.
    Schellong, Sebastian M.
    Schwocho, Lee
    Segers, Annelise
    Shi, Minggao
    Verhamme, Peter
    Wells, Phil
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (15): : 1406 - 1415
  • [26] Edoxaban Versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
    史振宇
    临床误诊误治, 2014, 27 (03) : 102 - 102
  • [27] Dabigatran or warfarin for extended maintenance therapy of venous thromboembolism
    Schulman, S.
    Eriksson, H.
    Goldhaber, S. Z.
    Kakkar, A. K. L.
    Kearon, C.
    Kvamme, A. M.
    Mismetti, P.
    Schellong, S.
    Schnee, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 731 - 732
  • [28] Treatment of venous thromboembolism with dabigatran
    Schulman, Sam
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (05) : 410 - 415
  • [29] Oral dabigatran etexilate for the prevention of venous thromboembolism after robotic prostatectomy
    Saily, V. M. J.
    Rannikko, A.
    Petas, A.
    Lassila, R.
    Taari, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E787 - U669
  • [30] Influence of Thrombophilia on the Efficacy of Dabigatran Versus Warfarin for the Extended Treatment of Acute Venous Thromboembolism in RE-MEDY
    Schulman, Sam
    Eriksson, Henry
    Goldhaber, Samuel Z.
    Kakkar, Ajay
    Kearon, Clive
    Schellong, Sebastian M.
    Feuring, Martin
    Friedman, Jeffrey
    Kreuzer, Joerg
    BLOOD, 2014, 124 (21)
12345